News from UNITAID
UNITAID Welcomes Sub- Licences to make Hepatitis C Drug Widely Available
Geneva, 19 January 2016 – UNITAID welcomes agreements to manufacture a key Hepatitis C medicine and make it available in many low- and middle-income countries. The Medicines Patent Pool (MPP), which is fully funded by UNITAID, signed licenses for the generic...
The Medicines Patent Pool and Abbvie Sign Licensing Agreement to Increase Access to Crucial HIV treatments Throughout Africa
Geneva, 18 December 2015 — The Medicines Patent Pool (MPP) today announced a new licensing agreement with AbbVie, a global biopharmaceutical company, that seeks to address future demands for HIV treatment Lopinavir/Ritonavir (LPV/r) in South Africa and across Africa....
UNITAID Reviews Landscape in Diagnostics Technology for HIV
UNITAID today released its 2015 HIV/AIDS Diagnostics Technology Landscape that summarizes the latest products and technologies to detect, stage and monitor HIV infection. The Landscape covers technologies including instruments for laboratories, multi-purpose platforms...